Literature DB >> 7882947

Fiber levels and disease in workers from a factory predominantly using amosite.

A R Gibbs1, M J Gardner, F D Pooley, D M Griffiths, B Blight, J C Wagner.   

Abstract

The Cape Boards Plant at Uxbridge produced insulation board containing amosite asbestos between 1947 and 1973 with only small amounts of chrysotile. After 1973 only amosite was used. In this study we examined lung samples from 48 workers who had been employed at the plant and who had come to autopsy. The study investigated the fiber levels against the lung pathology including amount of interstitial fibrosis and numbers of ferruginous bodies. The degree of interstitial fibrosis and number of asbestos bodies were graded and the tissues were analyzed by transmission electron microscopy and energy dispersive X-ray analysis and the fibers counted and typed. The 48 cases included 5 mesotheliomas and 14 lung cancers. The mineral analysis results were dominated by the amosite fiber levels. The amounts of chrysotile were relatively small. There were higher levels in lung cancer cases than mesotheliomas and higher levels in mesothelioma cases than those who had died from nonasbestos related diseases. Analysis of the lung tissues showed a consistent pattern of high amosite levels, which confirms the impression that amosite was the predominant form of asbestos used and also indicates that the factory had been a very dusty one.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7882947      PMCID: PMC1567264          DOI: 10.1289/ehp.94102s5261

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  10 in total

1.  Correlation between fibre content of the lungs and disease in naval dockyard workers.

Authors:  J C Wagner; C B Moncrieff; R Coles; D M Griffiths; D E Munday
Journal:  Br J Ind Med       Date:  1986-06

Review 2.  Health hazards of asbestos. Recent studies on its biological effects.

Authors:  J C Gilson
Journal:  Trans Soc Occup Med       Date:  1966-07

3.  Mesothelioma in a factory using amosite and chrysotile asbestos.

Authors:  E D Acheson; C Bennett; M J Gardner; P D Winter
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

4.  Quantitative assessment of inorganic fibrous particulates in dust samples with an analytical transmission electron microscope.

Authors:  F D Pooley; N J Clark
Journal:  Ann Occup Hyg       Date:  1979

5.  Mortality of two groups of women who manufactured gas masks from chrysotile and crocidolite asbestos: a 40-year follow-up.

Authors:  E D Acheson; M J Gardner; E C Pippard; L P Grime
Journal:  Br J Ind Med       Date:  1982-11

6.  Correlation between fibre content of the lung and disease in east London asbestos factory workers.

Authors:  J C Wagner; M L Newhouse; B Corrin; C E Rossiter; D M Griffiths
Journal:  Br J Ind Med       Date:  1988-05

7.  Mesotheliomas and asbestos type in asbestos textile workers: a study of lung contents.

Authors:  J C Wagner; G Berry; F D Pooley
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

8.  Cancer in a factory using amosite asbestos.

Authors:  E D Acheson; M J Gardner; P D Winter; C Bennett
Journal:  Int J Epidemiol       Date:  1984-03       Impact factor: 7.196

9.  The hygiene standard for chrysotile asbestos.

Authors:  J Peto
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

10.  Comparison of the results of asbestos fibre dust counts in lung tissue obtained by analytical electron microscopy and light microscopy.

Authors:  F D Pooley; D L Ranson
Journal:  J Clin Pathol       Date:  1986-03       Impact factor: 3.411

  10 in total
  2 in total

Review 1.  Analysis and interpretation of inorganic mineral particles in "lung" tissues.

Authors:  A R Gibbs; F D Pooley
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

2.  A risk assessment for exposure to grunerite asbestos (amosite) in an iron ore mine.

Authors:  R P Nolan; A M Langer; R Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.